Vitalhub Corp. (TSE:VHI - Get Free Report) shares hit a new 52-week high during trading on Tuesday . The stock traded as high as C$13.70 and last traded at C$13.49, with a volume of 110124 shares traded. The stock had previously closed at C$13.40.
Analysts Set New Price Targets
VHI has been the topic of several recent analyst reports. National Bank Financial upgraded shares of Vitalhub to a "strong-buy" rating in a report on Monday, June 9th. Raymond James Financial lifted their target price on shares of Vitalhub from C$13.50 to C$14.00 and gave the stock an "outperform" rating in a report on Friday, June 20th. Scotiabank lifted their target price on shares of Vitalhub from C$14.00 to C$14.50 and gave the stock an "outperform" rating in a report on Friday, June 20th. Finally, National Bankshares set a C$14.00 target price on shares of Vitalhub and gave the stock an "outperform" rating in a report on Tuesday, June 10th. Six investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of C$13.25.
Read Our Latest Research Report on Vitalhub
Vitalhub Stock Performance
The company has a market capitalization of C$731.87 million, a price-to-earnings ratio of 220.06, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26. The firm's 50-day simple moving average is C$11.50 and its 200-day simple moving average is C$10.80.
Insider Transactions at Vitalhub
In related news, Director Francis Nelson Shen purchased 25,000 shares of the firm's stock in a transaction on Friday, May 16th. The shares were bought at an average cost of C$10.23 per share, for a total transaction of C$255,750.00. 18.57% of the stock is owned by corporate insiders.
Vitalhub Company Profile
(
Get Free Report)
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Read More
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access